Lobbying

Neurofibromatosis Network's latest lobbying report covers Q2 2026, at $20K. The four quarters Q3 2025–Q2 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Defense.

Neurofibromatosis Network

Latest quarter
$20K
Q2 2026 · 1 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
+100.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Neurofibromatosis Network lobbying by quarter
Neurofibromatosis Network lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$20K1
Q3 2025$10K1
Q4 2025$20K1
Q1 2026$10K1
Q2 2026$20K1

Policy issues the reports name

  • Budget and appropriations15 reports
  • Defense15 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Army, Dept of (Other)1 reports

Firms it paid

Firm
Van Scoyoc Associates$180K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/17for Q2Van Scoyoc Associates$20K
04/17for Q1Van Scoyoc Associates$10K
01/19for Q4 2025Van Scoyoc Associates$20K
25/10/17for Q3 2025Van Scoyoc Associates$10K
25/07/18for Q2 2025Van Scoyoc Associates$20K
25/04/18for Q1 2025Van Scoyoc Associates$10K
25/01/20for Q4 2024Van Scoyoc Associates$10K
24/10/18for Q3 2024Van Scoyoc Associates$10K
24/07/19for Q2 2024Van Scoyoc Associates$10K
24/04/19for Q1 2024Van Scoyoc Associates$10K
24/01/19for Q4 2023Van Scoyoc Associates$10K
23/10/19for Q3 2023Van Scoyoc Associates$10K
23/07/19for Q2 2023Van Scoyoc Associates$10K
23/04/19for Q1 2023Van Scoyoc Associates$10K
23/01/19for Q4 2022Van Scoyoc Associates$10K